Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1Phase 2/3 1Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 406Neoplasms 367Prostatic Neoplasms 194Lung Neoplasms 185Colorectal Neoplasms 136Motor Activity 84Pancreatic Neoplasms 77Uterine Cervical Neoplasms 74Carcinoma, Non-Small-Cell Lung 72Head and Neck Neoplasms 67Brain Neoplasms 67Ovarian Neoplasms 59Carcinoma, Hepatocellular 50Neoplasm Metastasis 48Rectal Neoplasms 46Colonic Neoplasms 45Anxiety Disorders 45Precursor Cell Lymphoblastic Leukemia-Lymphoma 43Hematologic Neoplasms 39Depression 38Melanoma 36Glioblastoma 35Glioma 34Disease 34Multiple Myeloma 33Sarcoma 32Gastrointestinal Neoplasms 32Urinary Bladder Neoplasms 31Stomach Neoplasms 31Pain 31

Interventions

Injections, Intralesional 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Lymphatic Abnormalities × 90 days × Clear all
NCT07189832 2026-04-28

Bleomycin Intralesional Injections of Cystic Hygromas

Delta University for Science and Technology

Phase NA Completed
30 enrolled

Lymphangioma, Cystic, Lymphatic Abnormalities

Data powered by HemOnc (CC BY 4.0) Colophon âš¡